Tesu Health
Tesu Health is a UK-based digital therapeutics company focused on reversing chronic conditions through evidence-based, user-friendly digital therapies. Their flagship product, PreDiaWell®, is a clinically validated digital therapeutic designed to prevent type 2 diabetes by empowering individuals with personalized, interactive, and AI-driven interventions that promote sustainable lifestyle changes. The company targets individuals, healthcare providers, and partners with scalable solutions that integrate into existing healthcare systems. Tesu Health emphasizes clinical validation, regulatory compliance, and patient safety, with PreDiaWell® backed by randomized controlled trials demonstrating significant health improvements such as HbA1c reduction and weight loss. Their business model includes digital therapeutics delivered via mobile apps, supported by healthcare partnerships and employer wellness programs, positioning them as an innovative player in chronic disease management and prevention.
Tesu Health
Tesu Health is a UK-based digital therapeutics company focused on reversing chronic conditions through evidence-based, user-friendly digital therapies. Their flagship product, PreDiaWell®, is a clinically validated digital therapeutic designed to prevent type 2 diabetes by empowering individuals with personalized, interactive, and AI-driven interventions that promote sustainable lifestyle changes. The company targets individuals, healthcare providers, and partners with scalable solutions that integrate into existing healthcare systems. Tesu Health emphasizes clinical validation, regulatory compliance, and patient safety, with PreDiaWell® backed by randomized controlled trials demonstrating significant health improvements such as HbA1c reduction and weight loss. Their business model includes digital therapeutics delivered via mobile apps, supported by healthcare partnerships and employer wellness programs, positioning them as an innovative player in chronic disease management and prevention.